BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 26194091)

  • 1. Childhood acute lymphoblastic leukemia: Integrating genomics into therapy.
    Tasian SK; Loh ML; Hunger SP
    Cancer; 2015 Oct; 121(20):3577-90. PubMed ID: 26194091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic characterization of paediatric acute lymphoblastic leukaemia: an opportunity for precision medicine therapeutics.
    Tasian SK; Hunger SP
    Br J Haematol; 2017 Mar; 176(6):867-882. PubMed ID: 27984637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genomic landscape of pediatric acute lymphoblastic leukemia and precision medicine opportunities.
    Tran TH; Hunger SP
    Semin Cancer Biol; 2022 Sep; 84():144-152. PubMed ID: 33197607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biology of childhood acute lymphoblastic leukemia.
    Bhojwani D; Yang JJ; Pui CH
    Pediatr Clin North Am; 2015 Feb; 62(1):47-60. PubMed ID: 25435111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights of Acute Lymphoblastic Leukemia with Development of Genomic Investigation.
    Xu H; Shu Y
    Methods Mol Biol; 2018; 1754():387-413. PubMed ID: 29536454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic characterization of childhood acute lymphoblastic leukemia.
    Mullighan CG
    Semin Hematol; 2013 Oct; 50(4):314-24. PubMed ID: 24246699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-Generation Sequencing in Acute Lymphoblastic Leukemia.
    Coccaro N; Anelli L; Zagaria A; Specchia G; Albano F
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31208040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular-based and antibody-based targeted pharmacological approaches in childhood acute lymphoblastic leukemia.
    Tardif M; Souza A; Krajinovic M; Bittencourt H; Tran TH
    Expert Opin Pharmacother; 2021 Oct; 22(14):1871-1887. PubMed ID: 34011251
    [No Abstract]   [Full Text] [Related]  

  • 9. New strategies in acute lymphoblastic leukemia: translating advances in genomics into clinical practice.
    Mullighan CG
    Clin Cancer Res; 2011 Feb; 17(3):396-400. PubMed ID: 21149616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy for childhood acute lymphoblastic leukemia.
    Cassano WF; Eskenazi AE; Frantz CN
    Curr Opin Oncol; 1993 Jan; 5(1):42-52. PubMed ID: 8427893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic and germline genomics in paediatric acute lymphoblastic leukaemia.
    Pui CH; Nichols KE; Yang JJ
    Nat Rev Clin Oncol; 2019 Apr; 16(4):227-240. PubMed ID: 30546053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of genomics for risk stratification of childhood acute lymphoblastic leukaemia: from bench to bedside?
    Izraeli S
    Br J Haematol; 2010 Oct; 151(2):119-31. PubMed ID: 20678159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FPGS relapse-specific mutations in relapsed childhood acute lymphoblastic leukemia.
    Yu SL; Zhang H; Ho BC; Yu CH; Chang CC; Hsu YC; Ni YL; Lin KH; Jou ST; Lu MY; Chen SH; Wu KH; Wang SC; Chang HH; Pui CH; Yang JJ; Zhang J; Lin DT; Lin SW; Ma X; Yang YL
    Sci Rep; 2020 Jul; 10(1):12074. PubMed ID: 32694622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The biology of relapsed acute lymphoblastic leukemia: opportunities for therapeutic interventions.
    Bhatla T; Jones CL; Meyer JA; Vitanza NA; Raetz EA; Carroll WL
    J Pediatr Hematol Oncol; 2014 Aug; 36(6):413-8. PubMed ID: 24942023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling gene mutations, translocations, and multidrug resistance in pediatric acute lymphoblastic leukemia: a step forward to personalizing medicine.
    Rose-James A; Shiji R; Kusumakumary P; Nair M; George SK; Sreelekha TT
    Med Oncol; 2016 Sep; 33(9):98. PubMed ID: 27449773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Childhood and adolescent lymphoid and myeloid leukemia.
    Pui CH; Schrappe M; Ribeiro RC; Niemeyer CM
    Hematology Am Soc Hematol Educ Program; 2004; ():118-45. PubMed ID: 15561680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Panel-based next-generation sequencing identifies prognostic and actionable genes in childhood acute lymphoblastic leukemia and is suitable for clinical sequencing.
    Ishida H; Iguchi A; Aoe M; Takahashi T; Tamefusa K; Kanamitsu K; Fujiwara K; Washio K; Matsubara T; Tsukahara H; Sanada M; Shimada A
    Ann Hematol; 2019 Mar; 98(3):657-668. PubMed ID: 30446805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic profiling of B-progenitor acute lymphoblastic leukemia.
    Mullighan CG
    Best Pract Res Clin Haematol; 2011 Dec; 24(4):489-503. PubMed ID: 22127311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and Epigenetic Targeting Therapy for Pediatric Acute Lymphoblastic Leukemia.
    Xu H; Yu H; Jin R; Wu X; Chen H
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?
    Pui CH; Mullighan CG; Evans WE; Relling MV
    Blood; 2012 Aug; 120(6):1165-74. PubMed ID: 22730540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.